Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cancer cell adhesion is a broad term describing how tumor cells interact with each other and the surrounding stroma via cell adhesion molecules (CAMs). CAMs are a diverse group, including cadherins, integrins, selectins, and members of the immunoglobulin superfamily, that enable tumor cell invasion, metastasis, and communication with the microenvironment. Disruption or modulation of adhesion can enable cancer spread (metastasis), while altered expression or function is often observed in malignancy. As a process, cancer cell adhesion is a therapeutic interest area, but not a specific molecular target—it encompasses multiple pathways and receptor families rather than a distinct targetable entity[1][3][2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cancer cell adhesion.